Stanford Medicine Webinar: Modern Treatment of Retinopathy of Prematurity
Insights on Anti-Vascular Endothelial Growth Factor Agents
Stanford Medicine Webinar: Modern Treatment of Retinopathy of Prematurity
Insights on Anti-Vascular Endothelial Growth Factor Agents
Stanford University School of Medicine
291 Campus Drive
CA 94305-5101 Stanford
-
Basisinformation
Datum10.02.2025, 19:00 - 21:00SpracheEnglischGebühren abgebührenfreiVeranstalterStanford University School of Medicine
OrganisatorStanford University School of Medicine
291 Campus Drive
CA 94305-5101 Stanford -
Programm
Dr. Darius Moshfeghi, Dr. Adiel Barak, Dr. Daphna Mezad, and Prof. Anat Loewenstein will discuss the efficacy, application, and research surrounding these therapies in the management of ROP. The session aims to provide a comprehensive overview of how these treatments are altering the standard of care, as well as the implications for patient outcomes. The panelists will also discuss case examples, followed by a Q&A session.
Agenda:
Welcome and Opening Remarks - 5 min
ROP Overview - 20 min
Debate: Laser for PAR after Anti-VEGF: Always vs Never - 15 min
Case Studies Presentations - 15 min
Summary and Q&A - 5 min
Panelists:
Dr. Darius Moshfeghi, Chief of the Retina Division and Professor of Ophthalmology, at the Stanford University School of Medicine
Dr. Adiel Barak, Professor of Ophthalmology, Head of Surgical Retina, Tel Aviv Medical Center, Tel Aviv University
Dr. Daphna Mezad, Senior Lecturer of Ophthalmology, Head of Pediatric Ophthalmology, Tel Aviv Medical Center, Tel Aviv University
Prof. Anat Loewenstein, Head of Retina, Division of Ophthalmology, Deputee CEO, Tel Aviv Medical Center; Sidney Fox Chair of Ophthalmology, Tel Aviv University
-
Gebühren
Fachärzte/-innenGebühren abgebührenfrei
- Buchung / Anmeldung
-
Zertifizierung
Zertifizierung unbekannt